마크로젠

Business Overview

MacroGen, established in 1997, is a precision medicine biotechnology company specializing in genome analysis, offering services such as genome sequencing, oligo synthesis, microarray analysis, and genetically modified mouse production through global genomics centers. Its core business, genome analysis services, accounts for approximately 90% of total revenue, utilizing both CES and NGS technologies to analyze genetic sequences across humans and various organisms. The company enhances its competitive edge by integrating blockchain and AI technologies for data security and expanding into new service areas.